A Personal Cancer Vaccine (NEO-PV-01) and APX005M or Ipilimumab With Nivolumab in Patients With Advanced Melanoma

Stopped Closed due to historically slow enrollment compounded by the COVID-19 pandemic.

Conditions

• Metastatic Melanoma

Interventions

• BIOLOGICAL: NEO-PV-01
• BIOLOGICAL: Nivolumab
• OTHER: Adjuvant
• BIOLOGICAL: APX005M
• BIOLOGICAL: ipilimumab

Sponsor

BioNTech US Inc.

Collaborators

• [object Object]